These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 27673859)

  • 1. A Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme.
    Azoulay M; Ho CK; Fujimoto DK; Modlin LA; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Nagpal S; Thomas R; Recht L; Choi CY; Soltys SG
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2S):E131-E132. PubMed ID: 27673859
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
    Vordermark D; Kölbl O
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
    [No Abstract]   [Full Text] [Related]  

  • 5. Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.
    Okonogi N; Shirai K; Oike T; Murata K; Noda SE; Suzuki Y; Nakano T
    Anticancer Res; 2015 Mar; 35(3):1229-35. PubMed ID: 25750269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.
    Hopewell JW; Gorlia T; Pellettieri L; Giusti V; H-Stenstam B; Sköld K
    Appl Radiat Isot; 2011 Dec; 69(12):1737-40. PubMed ID: 21482122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
    Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
    Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial.
    Cho DY; Yang WK; Lee HC; Hsu DM; Lin HL; Lin SZ; Chen CC; Harn HJ; Liu CL; Lee WY; Ho LH
    World Neurosurg; 2012; 77(5-6):736-44. PubMed ID: 22120301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy of glioblastoma.
    Barani IJ; Larson DA
    Cancer Treat Res; 2015; 163():49-73. PubMed ID: 25468225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
    Akasaki Y; Kikuchi T; Homma S; Koido S; Ohkusa T; Tasaki T; Hayashi K; Komita H; Watanabe N; Suzuki Y; Yamamoto Y; Mori R; Arai T; Tanaka T; Joki T; Yanagisawa T; Murayama Y
    Cancer Immunol Immunother; 2016 Dec; 65(12):1499-1509. PubMed ID: 27688162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes.
    Azoulay M; Chang SD; Gibbs IC; Hancock SL; Pollom EL; Harsh GR; Adler JR; Harraher C; Li G; Hayden Gephart M; Nagpal S; Thomas RP; Recht LD; Jacobs LR; Modlin LA; Wynne J; Seiger K; Fujimoto D; Usoz M; von Eyben R; Choi CYH; Soltys SG
    Neuro Oncol; 2020 Aug; 22(8):1182-1189. PubMed ID: 32002547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
    Trone JC; Vallard A; Sotton S; Ben Mrad M; Jmour O; Magné N; Pommier B; Laporte S; Ollier E
    Radiat Oncol; 2020 Jun; 15(1):145. PubMed ID: 32513205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma Treatment Modalities besides Surgery.
    Zhang H; Wang R; Yu Y; Liu J; Luo T; Fan F
    J Cancer; 2019; 10(20):4793-4806. PubMed ID: 31598150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma.
    Rajani KR; Carlstrom LP; Parney IF; Johnson AJ; Warrington AE; Burns TC
    Front Oncol; 2018; 8():656. PubMed ID: 30854331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Hypofractionation Radiation Strategies for Glioblastoma.
    Azoulay M; Shah J; Pollom E; Soltys SG
    Curr Oncol Rep; 2017 Sep; 19(9):58. PubMed ID: 28735440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The radiosurgery fractionation quandary: single fraction or hypofractionation?
    Kirkpatrick JP; Soltys SG; Lo SS; Beal K; Shrieve DC; Brown PD
    Neuro Oncol; 2017 Apr; 19(suppl_2):ii38-ii49. PubMed ID: 28380634
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.